SMSubhamita Maitra

Subhamita Maitra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Subhamita Maitra has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The standardized Centella asiatica extract ECa 233 regulates the catalytic activities of ?APP-cleaving secretases in human cell lines

    by Mehbuba Nur Protha, Therathep Srisutjarit, Arpita Dey, Subhamita Maitra, Jean-Francois Hernandez, Mayuree H. Tantisira, Yingrak Boondam, Narawut Pakaprot, Bruno Vincent

  • Open Access

    ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic system

    by Subhamita Maitra, Bruno Vincent

    Dopamine is a primary neurotransmitter associated with memory formation, emotional control, reward processing and other higher order mental functions. Altered dopamine signaling is implied in several neuropsychiatric, neurodevelopmental and neurodegenerative disorders including Alzheimer’s disease. Age-related memory decline often presents itself with spectrum of overtly behavioral responses in patients diagnosed with Alzheimer’s disease, thus suggesting that an alteration of dopaminergic transmission could account for the psychotic symptoms observed along the pathology. Since less sAPPα production due to reduced α-secretase activity is a direct contributor of compromised neuroprotection and can impart higher vulnerability to cellular insults, we explored the impact of specific inhibition of ADAM10, the main neuronal α-secretase, on dopamine system components in cultured human SH-SY5Y neuroblastoma cells. We found that dopamine receptor D4 protein levels were dose-dependently down regulated by GI254023X, but not by the ADAM17-specific inhibitor TAPI-0. We then established that GI254023X operates at a transcriptional levels. Furthermore, we showed that GI254023X treatment also significantly increased the levels of active PKA as well as the transcription of the dopamine-degrading enzymes catechol-O-methyltransferase, monoamine oxidase A and monoamine oxidase B. Altogether, our data propose that ADAM10 inhibition modulates the dopaminergic system to possibly trigger psychosis in Alzheimer’s disease.

  • Specific dopaminergic genetic variants influence impulsivity, cognitive deficit, and disease severity of Indian ADHD probands

    by Subhamita Maitra, Mahasweta Chatterjee, Anirban Roychowdhury, Chinmay Kumar Panda, Swagata Sinha, Kanchan Mukhopadhyay

    Background Impulsivity (Imp), being one of the cardinal symptoms of Attention Deficit Hyperactivity Disorder (ADHD), often leads to inappropriate responses to stimuli. Since the dopaminergic system is the primary target for pharmaceutical intervention in ADHD, we investigated the association between ADHD-related Imp and functional gene variants of the dopamine transporter (SLC6A3) and catechol-O-methyltransferase involved in dopamine clearance. Methods and results Indo-Caucasoid families with ADHD probands (N = 217) were recruited based on the Diagnostic and Statistical Manual of Mental Disorders (DSM). Imp of the probands was assessed using the Domain Specific Imp Scale for Children and DSM. Peripheral blood was collected after obtaining informed written consent for participation, genomic DNA was isolated, and target sites were genotyped by DNA sequencing. The association of genetic variants with Imp was examined by the Quantitative trait analysis (QTA) and Analysis of variance (ANOVA). Post-Hoc analysis following QTA and ANOVA showed significant associations of rs2254408, rs2981359, and rs2239393 with different domains of Imp (P < 0.05). Various haplotypic combinations also showed statistically significant associations with Imp (P < 0.05). Multifactor dimensionality reduction models revealed strong effects of the variants on Imp. ADHD probands harboring the risk alleles exhibited a deficit in performance during cognitive assessment. Longitudinal follow-up revealed a significant association of rs2254408 with trait persistence. Conclusion The present study indicates the influence of the studied genetic variants on ADHD-associated imp, executive deficit, and disease persistence. Thus, these variants may be helpful as predictors for the success of individual therapeutic sessions during cognitive training.